An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells

Immunology

Volumn 99, Issue 3, 2000, Pages 375-384

  Muller B ^a   Fischer, B ^a   Kreutz, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; NORMAL HUMAN; PH; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CULTURE MEDIA; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ERYTHROBLASTS; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HUMANS; HYDROGEN-ION CONCENTRATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034094734     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00975.x     Document Type: Article

References (40)

1. 1. Foa R., Guarini A. & Gansbacher B. (1992) IL2 treatment for cancer. from biology to gene therapy. Br J Cancer 66, 992.
2. 2. Parmiani G. (1990) An explanation of the variable clinical response to interleukin 2 and LAK cells. Immunol Today 11, 113.
3. 3. Mule J.J., Schwartz S.L., Roberts A.B., Sporn M.B. & Rosenberg S.A. (1988) Transforming growth factor-β inhibits in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 26, 95.
4. 4. Espevik J., Figari I.S., Ranges G.E. & Palladino M.A. Jr (1987) Transforming growth factor-β1 (TGF-β1) and recombinant human tumour necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity. J Immunol 140, 2312.
5. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med 3, 177.
6. 6. Gerweck L.E. (1998) Tumor pH. implications for treatment and novel drug design. Semin Rad Oncol 8, 176.
7. 7. Gerweck L.E. & Seetharaman K. (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 56, 1194.
8. 8. Wike-Hooley J.L., Havemann J. & Reinhold H.S. (1984) The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2, 343.
9. 9. Thistlethwaite A.J., Leeper D.B., Moylan D.J. III & Nerlinger R.E. (1985) pH distribution in human tumours. Int J Rad Oncol Biol Phys 11, 1647.
10. 10. Severin T., Müller B., Giese G. et al. (1994) pH-dependent LAK. cell cytotoxicity. Tumor Biol 15, 304.
11. 11. Fischer B., Müller B., Fisch P. & Kreutz W. (2000) An acidic microenvironment inhibits antitumoural non-MHC-restricted cytotoxicity: implications for the immunotherapy of cancer. J Immunother in press.
12. 12. Phillips J.H. & Lanier L.L. (1986) Dissection of the lymphokine-activated killer phenomenon relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 164, 814.
13. 13. Patarroyo M., Prieto J., Rincon J. et al. (1990) Leukocyte-cell adhesion. a molecular process fundamental in leukocyte physiology. Immunol Rev 114, 67.
14. 14. Rabinowich H., Herberman R.B. & Whiteside T. (1993) Differential effects of IL-12 and IL-2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol 152, 481.
15. + natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 23, 1831.
16. 16. Perussia B. (1991) Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 3, 49.
17. 17. Jääskeläinen J., Mäenpää A., Patarroyo M. et al. (1992) Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. J Immunol 149, 260.
18. 18. Figdor C.G., Van Kooyk Y. & Keizer G.D. (1990) On the mode of action of LFA-1. Immunol Today 11, 277.
19. 19. Stotter H., Wiebke E.A., Tomita S. et al. (1989) Cytokines alter target susceptibility to lysis. Evaluation of tumour infiltrating lymphocytes. J Immunol 142, 1767.
20. 20. Roehm N.W., Rodgers G.H., Hatfield S.M. & Glasebrook A.L. (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Meth 142, 257.
21. 21. Karimine N., Nanbara S., Arinaga S., Asoh T., Ueo H. & Akiyoshi T. (1994) Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph nodes, and tumour infiltrating lymphocytes in gastric cancer patients. J Surg Oncol 55, 179.
22. 22. Heun J., Müller B., Fischer B. & Kreutz W. (1998) Extracellular pH is an important regulator of receptor-ligand interactions. Immunobiology 199, 479.
23. 23. Robertson M.J., Caligiuri M.A., Manley T. J., Levine H. & Ritz J. (1990) Human natural killer cell adhesion molecules -differential expression after activation and participation in cytolysis. J Immunol 145, 3194.
24. 24. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A. & Boyd M.R. (1991) Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 51, 2515.
25. 25. Pross H.F. & Lotzová E. (1993) Role of natural killer cells in cancer. Nat Immun 12, 279.
26. 26. Kos F.J. & Engleman E.G. (1996) Immune regulation. a critical link between NK cells and CTLs. Immunol Today 17, 174.
27. 27. Lotzová E., Savary C.A. & HERBERMAN R.B. (1987) Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. J Immunol 138, 2718.
28. 28. Hiserodt J.C., Britvan L.J. & Targan S.R. (1982) Characterization of the cytolytic mechanism of the human natural killer (NK) cells. resolution into binding, programming for lysis and killer cell-independent steps. J Immunol 129, 1782.
29. 29. Mäenpää A., Jääskeläinen J., Carpen O., Patorroyo M. & Timonen T. (1993) Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short-and long-term cultures. Int J Cancer 53, 850.
30. 30. Timonen T., Gahmberg C.G. & Patarroyo M. (1990) Participation of CD11a-c/CD18, CD2 and RGD-binding receptors in endogenous and interleukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. Int J Cancer 46, 1035.
31. 31. Nitta T., Yagita H., Sato K. & Okumura K. (1989) Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction. J Immunol 143, 1757.
32. 32. Anasetti C., Martin P.J., June C.H. et al. (1987) Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J Immunol 139, 1772.
33. 33. Azuma M., Cayabyab M., Buck D., Phillips J.H. & Lanier L.L. (1992) Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 149, 1115.
34. 34. Nagler A., Lanier L.L., Cwirla S. & Phillips J.H. (1989) Comparative studies of human FcRIII-positive and -negative NK cells. J Immunol 143, 3183.
35. 35. Testi R. & Lanier L.L. (1989) Functional expression of CD28 on T cell antigen receptor γ/δ bearing T lymphocytes. Eur J Immunol 19, 185.
36. 36. Galandrini R., De Maria R., Piccoli M., Frati L. & Santoni A. (1994) CD44 triggering enhances human NK cell cytotoxic functions. J Immunol 153, 4399.
37. 37. Schoof D.D., Hunt P., Obando J.A. et al. (1992) Secondary cytokine production by lymphoid cells used in cellular immunotherapy. Surg Oncol 1, 163.
38. 38. Van Den Hove L.E., Van Gool S.W., Van Poppel H. et al. (1997) Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol 109, 501.
39. 39. Halperin M.L., Connors H.P., Relman A.S. & Karnovsky M.J. (1969) Factors that control the effect of pH on glycolysis in leukocytes. J Biol Chem 244, 348.
40. 40. Freyer J.P. (1998) Decreased mitochondrial function in quiescent cells isolated from multicellular tumor spheroids. J Cell Physiol 176, 138.